TP53 and cancer: In our previous report [8], we have shown, consistent with earlier studies, that BRCA1-associated cancers were diagnosed younger and were more ER- and progesterone-receptor-negative (PR-), more p53+, and of higher grade than unselected breast tumours or tumours from non-BRCA1/2 breast cancer families.